Ceylan, Arda H. http://orcid.org/0000-0002-9409-9288
Nascene, David R. http://orcid.org/0000-0002-2468-7359
Huang, Haitao http://orcid.org/0000-0003-3147-9352
Luedemann, Christopher http://orcid.org/0000-0001-5334-979X
Rubin, Nathan http://orcid.org/0000-0001-7162-5225
Özütemiz, Can http://orcid.org/0000-0002-4893-9725
Article History
Received: 3 March 2022
Accepted: 13 May 2022
First Online: 31 May 2022
Declarations
:
: This study was approved by the University of Minnesota Institutional Review Board (IRB #: STUDY00001646). For this type of study, formal consent is not required.
: This study was approved by the University of Minnesota Institutional Review Board (IRB #: STUDY00001646). For this type of study, formal consent is not required and the article is written in HIPAA-compliant fashion. Patients who opted out for research were not included.
: David Nascene: Consultant for Biogen and World Care Clinical.Nathan Rubin: Research reported in this publication was supported by NIH grant P30CA077598 utilizing the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota, and by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1-TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.The remainder of the authors declares that they have no conflict of interest.